U.S. Logistics Stock News

NYSE:SIG
NYSE:SIGSpecialty Retail

Signet Jewelers (SIG) Q4 EPS Concentration Reinforces Concerns Over Seasonal Profit Dependence

Signet Jewelers (SIG) closed FY 2026 with fourth quarter revenue of US$2.3 billion and basic EPS of US$6.16, alongside net income of US$250 million, setting the tone for what the full year meant for shareholders. Over the past year, the company has seen trailing twelve month revenue hold around US$6.8 billion, with basic EPS for the same period at US$7.13 and net income at US$294.4 million, giving you a clearer picture of how earnings have tracked through the year. Taken together, these...
NasdaqGS:FROG
NasdaqGS:FROGSoftware

A Look At JFrog (FROG) Valuation As Longer Term Returns Contrast With Recent Mixed Trading

Context for JFrog after recent trading moves JFrog (FROG) has seen mixed trading recently, with a 0.9% decline over the past day, a 3.7% gain over the past week, and weaker returns over the past month and past 3 months. See our latest analysis for JFrog. At a share price of $43.46, JFrog’s short term momentum has cooled, with a 30 day share price return of 8.63% and a 90 day share price return of 34.95%. Its 1 year total shareholder return of 28.31% and 3 year total shareholder return of...
NYSE:CRS
NYSE:CRSAerospace & Defense

Does New Positive Coverage and CEO Transition Shift the Bull Case for Carpenter Technology (CRS)?

Earlier this week, Carpenter Technology Corporation participated in the JPMorgan Industrials Conference 2026 in Washington, D.C., while investors reacted to fresh analyst coverage and upcoming CEO transition plans. The combination of new brokerage research highlighting Carpenter Technology’s role in advanced aerospace and defense alloys and the planned handover from CEO Tony Thene to COO Brian Malloy has sharpened market attention on how leadership and industry positioning may shape the...
NYSE:QGEN
NYSE:QGENLife Sciences

Qiagen’s TB And GI Testing Moves Draw Investor Valuation Interest

Qiagen (NYSE:QGEN) reported new clinical data supporting its QuantiFERON-TB Gold Plus test for tuberculosis infection, with a focus on immunocompromised and other high risk patient groups. The company is preparing for an international tuberculosis awareness event that will spotlight these findings and the role of blood based testing in infection detection. Qiagen also received FDA clearance for its QIAstat-Dx Gastrointestinal Panels on the higher throughput QIAstat-Dx Rise system for use in...
NasdaqGS:SAIL
NasdaqGS:SAILSoftware

SailPoint (SAIL) EPS Loss Narrows Sharply Challenging Longstanding Bearish Narratives

SailPoint (SAIL) has just wrapped up FY 2026 with fourth quarter revenue of US$294.6 million and a basic EPS loss of US$0.06, alongside a trailing twelve month revenue line of US$1.1 billion and a TTM basic EPS loss of US$0.54. Looking back over recent quarters, revenue has moved from US$235.3 million in Q3 2025 to US$240.1 million in Q4 2025, then to US$230.5 million in Q1 2026, US$264.4 million in Q2 2026, US$281.9 million in Q3 2026 and US$294.6 million in Q4 2026. Quarterly basic EPS...
NasdaqCM:SSII
NasdaqCM:SSIIMedical Equipment

A Look At SS Innovations International (SSII) Valuation After Earnings And Auditor Going Concern Warning

SS Innovations International (SSII) drew investor attention after releasing its 2025 results, which combined higher reported revenue with a smaller annual net loss and, at the same time, a going concern warning from auditor BDO LLP. See our latest analysis for SS Innovations International. At a share price of US$5.01, SS Innovations International has seen a 25% 1 month share price return, while the year to date share price return and 1 year total shareholder return remain negative. This hints...
NasdaqGM:ALVO
NasdaqGM:ALVOBiotechs

Alvotech (ALVO) TTM Profitability Challenged By Q4 US$108.5 Million Net Loss

FY 2025 earnings snapshot for Alvotech (NasdaqGM:ALVO) Alvotech (NasdaqGM:ALVO) closed FY 2025 with Q4 revenue of US$168.9 million and a basic EPS loss of US$0.44, as net income excluding extra items came in at a loss of US$108.5 million. The company has seen quarterly revenue range from US$102.99 million in Q3 2024 to US$173.3 million in Q2 2025, while basic EPS has swung between a loss of US$0.23 in Q4 2024 and a profit of US$0.39 in Q1 2025. This sets up a year where the trailing twelve...
NasdaqGS:KRYS
NasdaqGS:KRYSBiotechs

A Look At Krystal Biotech (KRYS) Valuation After Updated Vyjuvek Label And Pipeline Momentum

Label update and pipeline focus put Krystal Biotech in the spotlight Recent attention on Krystal Biotech (KRYS) centers on the FDA approval of an updated label for its gene therapy B-VEC/YJUVEK and on anticipation around its KB803 candidate for epidermolysis bullosa. See our latest analysis for Krystal Biotech. The recent FDA label update for B-VEC/YJUVEK and attention on KB803 come after a 36.79% 1 year total shareholder return. The 30 day share price return of 10.37% contrasts with a...
NYSE:OC
NYSE:OCBuilding

Has Owens Corning (OC) Fallen 28% Too Far For Its Fundamentals?

Wondering whether Owens Corning at around US$103 per share still offers value, or if the best days for this price are behind it? This article focuses squarely on what the current valuation is really telling you. The stock is roughly flat over the last week at a 0.3% gain, but that comes after a 22.6% decline over 30 days and a 28.0% decline over the past year, which can change how investors think about both risk and potential future returns. Recent headlines around Owens Corning have...
NasdaqGM:TATT
NasdaqGM:TATTAerospace & Defense

TAT Technologies (TATT) Margin Expansion To 9.4% Tests Bullish Efficiency Narrative

TAT Technologies (NasdaqGM:TATT) has wrapped up FY 2025 with fourth quarter revenue of US$46.5 million and basic EPS of US$0.36, capping a year in which trailing 12 month revenue reached US$178.0 million and EPS came in at US$1.39. Over recent periods the company has seen quarterly revenue move from US$41.0 million in Q4 2024 to US$46.5 million in Q4 2025. Basic EPS was US$0.36 a year ago and US$0.36 this quarter on a quarterly basis, and moved from US$1.08 to US$1.39 on a trailing 12 month...
NYSE:HAL
NYSE:HALEnergy Services

Halliburton (HAL) Valuation Check After Automated Well Placement Breakthrough In Guyana

Halliburton (HAL) is back in focus after reporting the industry’s first fully automated geological well placement offshore Guyana, a project that paired rig automation with real-time hydraulics to lift drilling efficiency. See our latest analysis for Halliburton. Halliburton’s recent Guyana automation milestone has arrived alongside firm price momentum, with the share price at $36.93 and a 90 day share price return of 33.23%, while the 1 year total shareholder return of 51.83% reflects recent...
NasdaqGM:ASST
NasdaqGM:ASSTMedical Equipment

Strive Asset Management (ASST) Q4 US$205.6m Loss Reinforces Bearish Earnings Narratives

Strive Asset Management (ASST) FY 2025 earnings snapshot Strive Asset Management (ASST) has just wrapped up FY 2025 with Q4 total revenue of about US$1.3 million and a loss per share of US$6.17, alongside a net loss excluding extra items of US$205.6 million, setting a stark backdrop for the latest numbers. Over the past year, revenue has moved from roughly US$0.8 million in Q2 2024 to US$1.3 million in Q4 2025, while trailing twelve month EPS shifted from a US$194.99 loss to a US$12.74 loss...
NYSE:MOD
NYSE:MODBuilding

Assessing Modine Manufacturing (MOD) Valuation After Strong Multi‑Period Share Price Momentum

Why Modine Manufacturing is on investors’ radar Modine Manufacturing (MOD) has drawn attention after recent share price swings, including a one-month return of 7% and a gain of 47.5% over the past three months, prompting fresh questions about what is already priced into the stock. See our latest analysis for Modine Manufacturing. At a share price of $200.87, Modine’s recent 4.66% 7 day share price return and 42.65% year to date share price return sit alongside a very large 5 year total...
NYSE:LTH
NYSE:LTHHospitality

What Life Time Group Holdings (LTH)'s Board Exit and New Analyst Coverage Means For Shareholders

On March 9, 2026, Life Time Group Holdings announced that Class I director Alejandro Santo Domingo would resign from its board effective March 31, 2026, while KeyBanc Capital Markets began covering the company with an Overweight rating amid favorable fitness-industry conditions. The coverage initiation underscores Life Time’s positioning as a premium fitness brand benefiting from rising interest in holistic health and wellness across age groups. Next, we’ll examine how KeyBanc’s positive...
NYSE:EPD
NYSE:EPDOil and Gas

Record EBITDA And Robust 2026 FCF Guidance Might Change The Case For Investing In Enterprise Products Partners (EPD)

In recent days, Enterprise Products Partners reported better-than-expected Q4 2025 results, including record quarterly EBITDA of US$2.70 billion, supported by new assets coming online and strong contract coverage across its Permian processing and export terminals. Management’s guidance for US$1.00 billion in free cash flow during 2026, with a large portion earmarked for buybacks and growth projects, highlights how its fee-based midstream model may reinforce cash generation even when...
NYSE:LUV
NYSE:LUVAirlines

Southwest Airlines (LUV) Is Up 5.9% After New Aircraft-Backed Loan And Raised 2026 Outlook

Southwest Airlines recently entered into a new US$500 million senior secured term loan facility maturing in 2029, backed by a pool of aircraft and related assets, while also presenting stronger-than-expected Q4 2025 results and raising its earnings outlook for 2026. This combination of fresh secured funding capacity and upgraded profitability guidance highlights how Southwest is simultaneously shoring up its balance sheet and signaling operating momentum. Next, we’ll examine how Southwest’s...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Is It Too Late To Consider Nebius Group (NBIS) After 364% One Year Surge?

If you are wondering whether Nebius Group's current share price reflects its true worth, the recent trading history gives you plenty to think about. The stock last closed at US$121.52, with returns of 12.5% over 7 days, 24.6% over 30 days, 35.1% year to date, and 364.3% over the past year. This will naturally raise questions about how much of the story is already priced in. Recent attention around Nebius Group has focused on its role in the software sector and how investors are treating high...
NasdaqGS:TITN
NasdaqGS:TITNTrade Distributors

Titan Machinery (TITN) EPS Loss Widens And Tests Bullish Profitability Narratives

Titan Machinery FY 2026 earnings snapshot Titan Machinery (TITN) has wrapped up FY 2026 with fourth quarter revenue of US$641.8 million and a basic EPS loss of US$1.59, while the trailing twelve months show revenue of US$2.4 billion and a basic EPS loss of US$2.38. Over recent quarters the company has seen revenue move from US$759.9 million in Q4 FY 2025 to US$641.8 million in Q4 FY 2026, with quarterly EPS swinging between a small profit of US$0.05 in Q3 FY 2026 and losses in the other...
NYSE:CAL
NYSE:CALSpecialty Retail

Caleres (CAL) Q4 EPS Loss Deepens And Tests Bullish Turnaround Narratives

Caleres (CAL) closed out FY 2026 with fourth quarter revenue of US$695.1 million and a basic EPS loss of US$0.68, while trailing twelve month revenue sat at about US$2.8 billion with a TTM basic EPS loss of US$0.21. Over recent quarters, the company has seen quarterly revenue move between US$614.2 million and US$790.1 million, with basic EPS ranging from a profit of US$0.21 in Q1 2026 to a loss of US$0.68 in Q4. This sets up a story where top line scale is in place but margin pressure is...
NYSE:TRC
NYSE:TRCReal Estate

Tejon Ranch (TRC) Q4 Profitability Rebound Challenges Bearish Earnings Narratives

Tejon Ranch (TRC) has just wrapped up FY 2025 with fourth quarter revenue of US$21.1 million and basic EPS of US$0.06, while the full year on a trailing 12 month basis came in at US$49.6 million of revenue and essentially breakeven EPS around US$0.00. Over recent quarters, the company has seen revenue move from US$8.3 million and basic EPS of a US$0.06 loss in Q2 2025 to US$11.0 million and a US$0.06 loss in Q3 2024, before reaching Q4 2025’s US$21.1 million and US$0.06 EPS. This sets up a...
NYSE:FCN
NYSE:FCNProfessional Services

How Investors May Respond To FTI Consulting (FCN) Expanding Its IQ.AI Legal Workflow Platform

In early March 2026, FTI Consulting’s Technology segment reported growing adoption of its IQ.AI platform among major corporate legal departments and law firms and introduced IQ.AI Studio, a proprietary library of generative AI tasks, models and workflows for complex legal, regulatory and investigation matters across multiple regions. The company highlighted that IQ.AI has already been used on hundreds of matters to compress timelines, reduce manual review workloads and extract structured...
NYSE:BAX
NYSE:BAXMedical Equipment

A Look At Baxter International (BAX) Valuation After CFO Change And Novum LVP Legal Scrutiny

Baxter International (BAX) is back in focus after chief financial officer Joel Grade stepped down. Interim CFO Anita Zielinski is stepping in as legal and governance questions around the Novum LVP infusion pump draw fresh investor attention. See our latest analysis for Baxter International. The share price has retreated sharply to US$16.66, with a 30 day share price return of a 19.67% decline and a 1 year total shareholder return of a 49.50% loss, reflecting fading momentum as investors...
NasdaqGS:PLAB
NasdaqGS:PLABSemiconductor

Photronics (PLAB) Is Up 12.0% After Earnings Beat And Expansion Update - What's Changed

Recently, Photronics reported a strong quarter with revenue increasing 6.1% year on year, surpassing analyst estimates for both sales and earnings per share. Management also emphasized that facility expansion and efforts to broaden the company’s geographic revenue mix are progressing, reflecting how it is adapting its photomask business to a more regionally segmented semiconductor industry. With this earnings beat and reaffirmed progress on facility expansion, we’ll now examine how the...